What we do know is that the emergence of drug tolerant melanoma cells is accompanied by a BRAF inhibitor-induced suppression of glycolysis 134 as well as dependence on mitochondrial biogenesis and oxidative phosphorylation 3, 135. Here, BRAF is linked to melanoma.